Grades of recommendation for antithrombotic agents

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 441S-444S

  Guyatt, Gordon H ^a   Cook, Deborah J ^a   Sackett, David L ^a   Eckman, Mark ^a   Pauker, Stephen ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ANTICOAGULATION; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; DRUG COST; HEART INFARCTION; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

EID: 0031760077     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.441S     Document Type: Conference Paper

References (11)

1. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95(suppl):2S-4S
2. Haas WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321:501-507
3. Guyatt GH, Sackett DL, Sinclair J, et al. Users' guides to the medical literature: IX. A method for grading health care recommendations. JAMA 1995; 274:1800-1804
4. Goodnight SH, Cairns JA. Therapeutic use of n-3 fatty acids for vascular disease and thrombosis. Chest 1995; 108(suppl): 302S-304S
5. Stein PD, Alpert JS, Copeland J, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1995; 108(suppl):371S-379S
6. Clagett CP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest 1995; 108(suppl):312S-334S
7. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 1554:1449-1457
8. Laupacis A, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation. Chest 108; 1995(suppl):352S-359S
9. Braitman LE. Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med 1991; 114:515-517
10. Guyatt G, Jaeschke R, Heddle N, et al. Basic statistics for clinicians: 2. Interpreting study results: confidence intervals. Can Med Assoc J 1995; 152:169-173
11. Cook DJ, Guyatt GH, Laupacis A, et al. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995; 108(suppl):227S-230S